Skip to main content

Navigation group

Type at least 3 characters
2,014 articles

Articles

Original Research

Published on 12 Jul 2022

Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

in Drugs Outcomes Research and Policies

  • Jelle M. Beernink
  • Milou M. Oosterwijk
  • Job F. M. van Boven
  • Hiddo J. L. Heerspink
  • Stephan J. L. Bakker
  • Gerjan Navis
  • Roos M. Nijboer
  • Christina M. Gant
  • Heleen Haverkate
  • Willemien J. Kruik-Kollöffel
Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Frontiers in Pharmacology
doi 10.3389/fphar.2022.888110
  • 5,249 views
  • 3 citations

Original Research

Published on 05 Jul 2022

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand

in Drugs Outcomes Research and Policies

  • Kanyawan Tiwattanon
  • Shobana John
  • Napatrupron Koomdee
  • Pimonpan Jinda
  • Jiratha Rachanakul
  • Thawinee Jantararoungtong
  • Nutthan Nuntharadthanaphong
  • Chiraphat Kloypan
  • Mohitosh Biswas
  • Apisit Boongird
Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
Frontiers in Pharmacology
doi 10.3389/fphar.2022.867490
  • 4,668 views
  • 9 citations

Systematic Review

Published on 01 Jul 2022

Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks

in Drugs Outcomes Research and Policies

  • Sanbao Chai
  • Fengqi Liu
  • Zhirong Yang
  • Shuqing Yu
  • Zuoxiang Liu
  • Qingqing Yang
  • Feng Sun
Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks
Frontiers in Pharmacology
doi 10.3389/fphar.2022.825417
  • 5,161 views
  • 20 citations

Original Research

Published on 29 Jun 2022

Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?

in Drugs Outcomes Research and Policies

  • Mariana do Rosário Souza
  • Wandklebson Silva da Paz
  • Vinícius Barbosa dos Santos Sales
  • Gleidson Felipe Hilario de Jesus
  • Débora dos Santos Tavares
  • Shirley V. M. Almeida Lima
  • Álvaro Francisco Lopes Sousa
  • Enaldo Vieira de Melo
  • Rodrigo Feliciano do Carmo
  • Carlos Dornels Freire de Souza
Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?
Frontiers in Pharmacology
doi 10.3389/fphar.2022.891711
  • 5,128 views
  • 24 citations